This inventor holds 1 USPTO granted patent. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anthony Gagliardi: Innovator in Genetic Research
Introduction
Anthony Gagliardi is a notable inventor based in Tarrytown, California. He has made significant contributions to the field of genetic research, particularly in the area of RNA agents. His work has implications for understanding and treating various genetic disorders.
Latest Patents
Gagliardi holds a patent for "Human Chromosome 9 Open Reading Frame 72 (C9ORF72) iRNA Agent Compositions and Methods of Use Thereof." This patent represents a crucial advancement in the development of therapeutic agents targeting specific genetic sequences.
Career Highlights
Anthony Gagliardi is currently employed at Alnylam Pharmaceuticals, Inc., a leading company in the field of RNA interference therapeutics. His role at Alnylam has allowed him to collaborate with other experts in the field, enhancing the impact of his research.
Collaborations
Gagliardi works alongside Elane Fishilevich, contributing to innovative projects that aim to push the boundaries of genetic research and therapeutic development.
Conclusion
Anthony Gagliardi's work exemplifies the intersection of innovation and genetic research, showcasing the potential of RNA agents in medical applications. His contributions continue to pave the way for advancements in the treatment of genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile